Literature DB >> 8054412

Clozapine-related tardive dyskinesia.

M Davé1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054412     DOI: 10.1016/0006-3223(94)90025-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  14 in total

1.  Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects.

Authors:  L Peacock; T Solgaard; H Lublin; J Gerlach
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

2.  Clozapine-associated Pisa syndrome: A rare type of tardive dystonia.

Authors:  Pattath Narayanan Suresh Kumar; Arun Gopalakrishnan
Journal:  Indian J Psychiatry       Date:  2017 Jul-Sep       Impact factor: 1.759

Review 3.  Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies.

Authors:  Katharina Stegmayer; Sebastian Walther; Peter van Harten
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

Review 4.  Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes.

Authors:  W W Fleischhacker; M Hummer
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 5.  Movement disorders: neurodevelopment and neurobehavioural expression.

Authors:  T Archer; R J Beninger
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

Review 6.  Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.

Authors:  Joseph M Pierre
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 7.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

8.  The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration.

Authors:  X M Gao; T Hashimoto; T B Cooper; C A Tamminga
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 9.  Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Authors:  Peter M Haddad; Sonu G Sharma
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 10.  Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.